82 related articles for article (PubMed ID: 22922206)
21. Pachastrissamine from Pachastrissa sp. inhibits melanoma cell growth by dual inhibition of Cdk2 and ERK-mediated FOXO3 downregulation.
Yoo H; Lee YS; Lee S; Kim S; Kim TY
Phytother Res; 2012 Dec; 26(12):1927-33. PubMed ID: 22451302
[TBL] [Abstract][Full Text] [Related]
22. Genomic analyses reveal global functional alterations that promote tumor growth and novel tumor suppressor genes in natural killer-cell malignancies.
Iqbal J; Kucuk C; Deleeuw RJ; Srivastava G; Tam W; Geng H; Klinkebiel D; Christman JK; Patel K; Cao K; Shen L; Dybkaer K; Tsui IF; Ali H; Shimizu N; Au WY; Lam WL; Chan WC
Leukemia; 2009 Jun; 23(6):1139-51. PubMed ID: 19194464
[TBL] [Abstract][Full Text] [Related]
23. [Molecular characterization of T/NK-cell malignancies].
Seto M; Yoshida N; Umino A; Karube K; Utsunomiya A
Rinsho Ketsueki; 2013 Jul; 54(7):628-35. PubMed ID: 23912345
[No Abstract] [Full Text] [Related]
24. Tumor-suppressive activity of 1,25-dihydroxyvitamin D3 against kidney cancer cells via up-regulation of FOXO3.
Lee J; Park SH
Biosci Biotechnol Biochem; 2016 Oct; 80(10):1947-53. PubMed ID: 27181027
[TBL] [Abstract][Full Text] [Related]
25. The PI3K/Akt/FOXO3a/p27Kip1 signaling contributes to anti-inflammatory drug-suppressed proliferation of human osteoblasts.
Li CJ; Chang JK; Chou CH; Wang GJ; Ho ML
Biochem Pharmacol; 2010 Mar; 79(6):926-37. PubMed ID: 19883628
[TBL] [Abstract][Full Text] [Related]
26. FOXO3-mediated up-regulation of Bim contributes to rhein-induced cancer cell apoptosis.
Wang J; Liu S; Yin Y; Li M; Wang B; Yang L; Jiang Y
Apoptosis; 2015 Mar; 20(3):399-409. PubMed ID: 25501496
[TBL] [Abstract][Full Text] [Related]
27. AKT activation drives the nuclear localization of CSE1L and a pro-oncogenic transcriptional activation in ovarian cancer cells.
Lorenzato A; Biolatti M; Delogu G; Capobianco G; Farace C; Dessole S; Cossu A; Tanda F; Madeddu R; Olivero M; Di Renzo MF
Exp Cell Res; 2013 Oct; 319(17):2627-36. PubMed ID: 23948303
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of Akt/FOXO3a signaling by constitutively active FOXO3a suppresses growth of follicular thyroid cancer cell lines.
Hong ZY; Lee HJ; Shin DY; Kim SK; Seo M; Lee EJ
Cancer Lett; 2012 Jan; 314(1):34-40. PubMed ID: 21974806
[TBL] [Abstract][Full Text] [Related]
29. LKB1 downregulation may be independent of promoter methylation or FOXO3 expression in head and neck cancer.
Ekizoglu S; Dalay N; Karaman E; Akdeniz D; Ozaydin A; Buyru N
Transl Res; 2013 Aug; 162(2):122-9. PubMed ID: 23810581
[TBL] [Abstract][Full Text] [Related]
30. Purified vitexin compound 1 inhibits growth and angiogenesis through activation of FOXO3a by inactivation of Akt in hepatocellular carcinoma.
Wang J; Zheng X; Zeng G; Zhou Y; Yuan H
Int J Mol Med; 2014 Feb; 33(2):441-8. PubMed ID: 24337611
[TBL] [Abstract][Full Text] [Related]
31. Knockdown of transcription factor forkhead box O3 (FOXO3) suppresses erythroid differentiation in human cells and zebrafish.
Wang H; Li Y; Wang S; Zhang Q; Zheng J; Yang Y; Qi H; Qu H; Zhang Z; Liu F; Fang X
Biochem Biophys Res Commun; 2015 May; 460(4):923-30. PubMed ID: 25843800
[TBL] [Abstract][Full Text] [Related]
32. Interleukin-2 induces NF-kappaB activation through BCL10 and affects its subcellular localization in natural killer lymphoma cells.
Chan KK; Shen L; Au WY; Yuen HF; Wong KY; Guo T; Wong ML; Shimizu N; Tsuchiyama J; Kwong YL; Liang RH; Srivastava G
J Pathol; 2010 Jun; 221(2):164-74. PubMed ID: 20235165
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of FOXO1/3 promotes vascular calcification.
Deng L; Huang L; Sun Y; Heath JM; Wu H; Chen Y
Arterioscler Thromb Vasc Biol; 2015 Jan; 35(1):175-83. PubMed ID: 25378413
[TBL] [Abstract][Full Text] [Related]
34. Threonine 32 (Thr32) of FoxO3 is critical for TGF-β-induced apoptosis via Bim in hepatocarcinoma cells.
Zhao X; Liu Y; Du L; He L; Ni B; Hu J; Zhu D; Chen Q
Protein Cell; 2015 Feb; 6(2):127-38. PubMed ID: 25503443
[TBL] [Abstract][Full Text] [Related]
35. Induction of Mxi1-SR alpha by FOXO3a contributes to repression of Myc-dependent gene expression.
Delpuech O; Griffiths B; East P; Essafi A; Lam EW; Burgering B; Downward J; Schulze A
Mol Cell Biol; 2007 Jul; 27(13):4917-30. PubMed ID: 17452451
[TBL] [Abstract][Full Text] [Related]
36. Loss of Mel-18 induces tumor angiogenesis through enhancing the activity and expression of HIF-1α mediated by the PTEN/PI3K/Akt pathway.
Park JH; Lee JY; Shin DH; Jang KS; Kim HJ; Kong G
Oncogene; 2011 Nov; 30(45):4578-89. PubMed ID: 21602890
[TBL] [Abstract][Full Text] [Related]
37. The phosphoinositide 3-kinase/Akt pathway regulates cell cycle progression of HL60 human leukemia cells through cytoplasmic relocalization of the cyclin-dependent kinase inhibitor p27(Kip1) and control of cyclin D1 expression.
Cappellini A; Tabellini G; Zweyer M; Bortul R; Tazzari PL; Billi AM; Falà F; Cocco L; Martelli AM
Leukemia; 2003 Nov; 17(11):2157-67. PubMed ID: 12931221
[TBL] [Abstract][Full Text] [Related]
38. FOXO3 is a latent tumor suppressor for FOXO3-positive and cytoplasmic-type gastric cancer cells.
Tsuji T; Maeda Y; Kita K; Murakami K; Saya H; Takemura H; Inaki N; Oshima M; Oshima H
Oncogene; 2021 Apr; 40(17):3072-3086. PubMed ID: 33795838
[TBL] [Abstract][Full Text] [Related]
39. Disruption to the FOXO-PRDM1 axis resulting from deletions of chromosome 6 in acute lymphoblastic leukaemia.
Sinclair PB; Cranston RE; Raninga P; Cheng J; Hanna R; Hawking Z; Hair S; Ryan SL; Enshaei A; Nakjang S; Rand V; Blair HJ; Moorman AV; Heidenreich O; Harrison CJ
Leukemia; 2023 Mar; 37(3):636-649. PubMed ID: 36670235
[TBL] [Abstract][Full Text] [Related]
40. Encoding Growth Factor Identity in the Temporal Dynamics of FOXO3 under the Combinatorial Control of ERK and AKT Kinases.
Sampattavanich S; Steiert B; Kramer BA; Gyori BM; Albeck JG; Sorger PK
Cell Syst; 2018 Jun; 6(6):664-678.e9. PubMed ID: 29886111
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
